 Comparison almitrine bismesylate medroxyprogesterone acetate oxygenation wakefulness sleep patients chronic obstructive lung disease effects almitrine bismesylate medroxyprogesterone acetate oxygenation wakefulness sleep patients chronic obstructive lung disease carbon dioxide retention Patients mg/kg almitrine peripheral chemoreceptor stimulant mg medroxyprogesterone central respiratory stimulant placebo days random order crossover trial subjects awake almitrine ventilatory response arterial oxygen tension extent medroxyprogesterone medroxyprogesterone ventilatory response arterial carbon dioxide tension extent almitrine drug influenced sleep architecture medroxyprogesterone number arousals Almitrine favourable effect placebo oxygenation arterial oxygen saturation different stages sleep number episodes hypoxaemia amount time change medroxyprogesterone comparison placebo decrease number hypoxaemic episodes active drugs blood gases wakefulness mg/kg almitrine superior mg medroxyprogesterone sleep